At a glance
ClinicalIndex Comparison RecordN/ACompleted· 49 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Pulmonary and Extra-pulmonary Characteristics in Severe-fatigued Allogeneic Hematopoietic Stem Cell Transplantation Recipients
In Brief
An observational study for Stem Cell Transplantation and Fatigue. Completed, enrolled 49 participants across 1 site.
Detailed Summary
Fatigue is a common symptom during allogeneic-hematopoietic stem cell transplantation (allo-HSCT). However, effects of severe fatigue on pulmonary functions, blood cells, dyspnea, muscle strength, exercise capacity, depression and quality of life (QOL) in allo-HSCT recipients are still unknown.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsStem Cell Transplantation, Fatigue
CountriesTurkey (Türkiye)
Collaborators--
Timeline
N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartMar 2012
Primary CompletionAug 2017
Study CompletionDec 2017
First PostedFeb 2018
TodayJul 2026
First PostedFeb 28, 2018
Enrollment StartMar 1, 2012
Primary CompletionAug 1, 2017
Study CompletionDec 1, 2017
TodayJul 2, 2026
Enrollment to primary: 5.4 yearsPosted 8.3 years ago